Monday, August 21, 2023 6:50:24 PM
65.88% daily short volume on Monday but PPS up 12%!
5.72 million shares (12.55% of the float) currently shorted
Current borrow fee: 10.45%
Shares available to borrow: 450'000
65.88% of the daily volume has been shorted on Monday (as reported by FINRA) but despite the attacks by the shorts the PPS went up 12%! The number of available shares for shorting is 450'000 and the borrow fee is 10.45% The overall number of shorted shares has increased by 700'000 over the last few weeks - just ask yourself who would short CVM at this stage. The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...
5.72 million shares (12.55% of the float) currently shorted
Current borrow fee: 10.45%
Shares available to borrow: 450'000
65.88% of the daily volume has been shorted on Monday (as reported by FINRA) but despite the attacks by the shorts the PPS went up 12%! The number of available shares for shorting is 450'000 and the borrow fee is 10.45% The overall number of shorted shares has increased by 700'000 over the last few weeks - just ask yourself who would short CVM at this stage. The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...
Bullish
Recent CVM News
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 05/27/2026 09:00:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 12:03:20 PM
- CEL-SCI Reports Fiscal Second Quarter 2026 Results • Business Wire • 05/18/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:44:06 PM
- CEL-SCI Announces Closing of Public Offering • Business Wire • 05/13/2026 07:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/12/2026 04:15:05 AM
- CEL-SCI Corporation Announces Pricing of Public Offering • Business Wire • 05/12/2026 12:11:00 AM
- CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia • Business Wire • 05/11/2026 12:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 09:07:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:03:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 10:59:38 AM
- CEL-SCI Reports Fiscal First Quarter 2026 Results • Business Wire • 02/18/2026 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 10:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 01:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:26:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:23:02 PM
- CEL-SCI Reports Fiscal 2025 Results • Business Wire • 12/29/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 01:48:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2025 10:00:37 PM
